• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    HEALTHCARE (NY:XLV)

    149.50 +2.93 (+2.00%)
    Streaming Delayed Price Updated: 3:52 PM EDT, Apr 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about HEALTHCARE

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    42 43 Next >
    News headline image
    The Great Balancing Act: U.S. Gender Labor Gap Closes for the First Time in History
    The long-standing "gender gap" in the American workforce has effectively closed. According to the Bureau of Labor Statistics (BLS) report released for the first quarter of 2026, the participation rate... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    What Q1 Earnings Could Mean for the S&P 500 Uptrend ↗
    Via MarketBeat
    Topics Stocks
    News headline image
    Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now ↗
    AbbVie has strong financials, a great dividend, and its stock trades at a modest valuation. 
    Via The Motley Fool
    Topics ETFs Intellectual Property
    BSX Stock Tumbles Pre-Market On Softer 2026 Sales Growth Forecast ↗
    Via Stocktwits
    Janux Stock Is Rising Pre-Market After A New Oncology Deal With Bristol Myers Squibb ↗
    Via Stocktwits
    News headline image
    The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery
    The biotech sector has found its new North Star in 2026. As of mid-March, Moderna Inc. (NASDAQ: MRNA) has shocked Wall Street with a staggering 83% year-to-date gain, catapulting it to the upper... 
    Via MarketMinute
    Topics Artificial Intelligence Initial Public Offering Stocks
    News headline image
    The S&P 500's 3 Best-Performing Stocks so far in 2026 ↗
    Via MarketBeat
    Topics Stocks
    News headline image
    HELP Stock Tanks 22% Despite Strong Phase 2 Results For Anxiety Treatment: Retail Buys The Dip Ignoring Market’s Pessimism ↗
    In the study, participants receiving a 20-milligram dose of HLP004 alongside standard-of-care treatment experienced an average drop of roughly 10.4 points on the Hamilton Anxiety Rating Scale after six... 
    Via Stocktwits
    News headline image
    The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
    As of late February 2026, the financial narrative of the past two years has been dominated by a singular force in the healthcare sector: Eli Lilly & Company (NYSE: LLY). Once considered a traditional... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs
    News headline image
    Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue ↗
    The company generated $147 million in revenue during Q4, a 67% year-on-year (YoY) increase. Earnings per share (EPS) for the quarter were $0.11. 
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 ↗
    Bank of America reduced its rating on PROCEPT BioRobotics to ‘Underperform’ from ‘Neutral’. 
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Why Did CASI Stock Plummet 64% Today To Hit An All-Time Low? ↗
    CASI stated the Nasdaq determined that the company had failed to satisfy the continued listing conditions to remain listed on the Nasdaq Stock Market. 
    Via Stocktwits
    News headline image
    Why Did IXHL Stock Tank Over 32% Today? ↗
    The company’s board approved a 1-for-30 reverse stock split, effective on February 26. 
    Via Stocktwits
    News headline image
    Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? ↗
    The FDA has granted Breakthrough Therapy Designation to Larimar’s frataxin protein replacement therapy, nomlabofusp. 
    Via Stocktwits
    News headline image
    VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership ↗
    Raymond James analyst Sean McCutcheon upgraded the stock to ‘Strong Buy’ from ‘Outperform’ and lifted his price target to $19 from $12. 
    Via Stocktwits
    News headline image
    Why Did IOVA Stock Gain Pre-Market Today? ↗
    The company announced encouraging early results from a pilot study evaluating its tumor-infiltrating lymphocyte therapy, lifileucel and reported strong fourth-quarter earnings. 
    Via Stocktwits
    News headline image
    Why Is GRAL Stock Down Today? Analysts Lower Targets After UK Trial Setback But Call Selloff Overdone ↗
    Baird analyst Catherine Ramsey Schulte slashed the price target on Grail to $82 from $113 while reiterating an ‘Outperform’ rating. 
    Via Stocktwits
    News headline image
    Why Did INTS Stock Plummet 30% Pre-Market Today? ↗
    Intensity Therapeutics announced a 1-for-25 reverse stock split, consolidating every 25 existing shares into a single new share. 
    Via Stocktwits
    News headline image
    Why Did IMUX Stock Surge 33% Pre-Market Today? ↗
    Immunic announced a private placement of up to $400 million to support its clinical studies and other operational needs. 
    Via Stocktwits
    News headline image
    Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now ↗
    Healthcare stocks have lagged the market for years, but 2026 is looking much better. 
    Via The Motley Fool
    Topics Artificial Intelligence ETFs Economy
    News headline image
    5 Stocks and ETFs to Help Shield Your Portfolio During Volatility ↗
    Via MarketBeat
    Topics ETFs
    News headline image
    LLY Stock Climbs Pre-Market On $2.4 Deal To Acquire Orna Therapeutics ↗
    The acquisition will strengthen Lilly’s pipeline with a new class of therapies built on engineered circular RNA and proprietary lipid nanoparticles. 
    Via Stocktwits
    News headline image
    Harel Insurance Sold $330 Million of Invesco KBW Bank ETF ↗
    Invesco KBW Bank ETF tracks a benchmark of major U.S. banking institutions, offering targeted sector exposure and a moderate yield. 
    Via The Motley Fool
    Topics ETFs Regulatory Compliance
    News headline image
    UNH Stock Craters To 6-Month Low: Piper Sandler Still Sees 40% Upside, Would Buy The Dip ↗
    UnitedHealth expects some membership contraction in 2026 and noted that CMS’s Medicare rate “simply doesn't reflect the reality.” 
    Via Stocktwits
    News headline image
    ALT Stock Surges Toward Sixth Straight Day Of Gains: Retail Bets A Buyout Is On The Horizon ↗
    Altimmune plans to raise $75 million via a direct offering to bankroll its Phase 3 MASH trial, easing near-term funding risk. 
    Via Stocktwits
    News headline image
    INMD Stock Jumped Nearly 13% Today – What’s Powering The Rally? ↗
    According to a Calcalist report, the company is set to go private after a $1.1 billion acquisition by a fund. 
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Revolution Medicines Stock Stares At Big Dip After Merck Reportedly Shelves Buyout — But Analyst Flags Opportunity ↗
    Stifel expects dip-buyers to step in, saying it would be surprised to see RVMD settle meaningfully below $100, calling the failed talks an “M&A clearing event.” 
    Via Stocktwits
    News headline image
    The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
    The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence... 
    Via MarketMinute
    Topics Artificial Intelligence Economy
    News headline image
    Why Did Corcept Therapeutics Stock Surge Over 14% Today? ↗
    In the ROSELLA trial, patients receiving relacorilant with nab-paclitaxel saw their risk of death drop by about 35% compared with those given the chemotherapy alone. 
    Via Stocktwits
    News headline image
    Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗
    ARK doubles down on a CRISPR bet as Intellia Therapeutics’ stock heads for its best week since October. 
    Via Stocktwits
    Topics Artificial Intelligence ETFs
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    42 43 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.